Wanting forward, Piller stays cautiously optimistic. Regardless of the setbacks and missteps, he sees a area prepared for change, pushed by scientists decided to discover new avenues. Whether or not it is analysis into infections, tau proteins, or GLP-1 inhibitors, recent views provide renewed hope.
